HER2 is not a cancer subtype but rather a pan-cancer event and is highly enriched in AR-driven breast tumors

Bibliographic Details
Title: HER2 is not a cancer subtype but rather a pan-cancer event and is highly enriched in AR-driven breast tumors
Authors: Anneleen Daemen, Gerard Manning
Source: Breast Cancer Research, Vol 20, Iss 1, Pp 1-16 (2018)
Publisher Information: BMC, 2018.
Publication Year: 2018
Collection: LCC:Neoplasms. Tumors. Oncology. Including cancer and carcinogens
Subject Terms: Breast cancer, Cancer, Amplification, ERBB2, Genomic characterization, PAM50, Neoplasms. Tumors. Oncology. Including cancer and carcinogens, RC254-282
More Details: Abstract Background Approximately one in five breast cancers are driven by amplification and overexpression of the human epidermal growth factor receptor 2 (HER2) receptor kinase, and HER2-enriched (HER2E) is one of four major transcriptional subtypes of breast cancer. We set out to understand the genomics of HER2 amplification independent of subtype, and the underlying drivers and biology of HER2E tumors. Methods We investigated published genomic data from 3155 breast tumors and 5391 non-breast tumors. Results HER2 amplification is a distinct driver event seen in all breast cancer subtypes, rather than a subtype marker, with major characteristics restricted to amplification and overexpression of HER2 and neighboring genes. The HER2E subtype has a distinctive transcriptional landscape independent of HER2A that reflects androgen receptor signaling as replacement for estrogen receptor (ER)-driven tumorigenesis. HER2 amplification is also an event in 1.8% of non-breast tumors. Conclusions These discoveries reveal therapeutic opportunities for combining anti-HER2 therapy with anti-androgen agents in breast cancer, and highlight the potential for broader therapeutic use of HER2 inhibitors.
Document Type: article
File Description: electronic resource
Language: English
ISSN: 1465-542X
Relation: http://link.springer.com/article/10.1186/s13058-018-0933-y; https://doaj.org/toc/1465-542X
DOI: 10.1186/s13058-018-0933-y
Access URL: https://doaj.org/article/4f53d8617e5b45919fe188f764a4ed34
Accession Number: edsdoj.4f53d8617e5b45919fe188f764a4ed34
Database: Directory of Open Access Journals
More Details
ISSN:1465542X
DOI:10.1186/s13058-018-0933-y
Published in:Breast Cancer Research
Language:English